Cargando…

Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate

The hypoxia-inducible factor 1α (HIF-1α) and its microRNA target, miR-210, are candidate tumor-drivers of metabolic reprogramming in cancer. Neuroendocrine neoplasms such as paragangliomas (PGLs) are particularly appealing for understanding the cancer metabolic adjustments because of their associati...

Descripción completa

Detalles Bibliográficos
Autores principales: Merlo, Anna, Bernardo-Castiñeira, Cristóbal, Sáenz-de-Santa-María, Inés, Pitiot, Ana S, Balbín, Milagros, Astudillo, Aurora, Valdés, Nuria, Scola, Bartolomé, Del Toro, Raquel, Méndez-Ferrer, Simón, I Piruat, José, Suarez, Carlos, Chiara, María-Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351664/
https://www.ncbi.nlm.nih.gov/pubmed/28036268
http://dx.doi.org/10.18632/oncotarget.14265
_version_ 1782514806803136512
author Merlo, Anna
Bernardo-Castiñeira, Cristóbal
Sáenz-de-Santa-María, Inés
Pitiot, Ana S
Balbín, Milagros
Astudillo, Aurora
Valdés, Nuria
Scola, Bartolomé
Del Toro, Raquel
Méndez-Ferrer, Simón
I Piruat, José
Suarez, Carlos
Chiara, María-Dolores
author_facet Merlo, Anna
Bernardo-Castiñeira, Cristóbal
Sáenz-de-Santa-María, Inés
Pitiot, Ana S
Balbín, Milagros
Astudillo, Aurora
Valdés, Nuria
Scola, Bartolomé
Del Toro, Raquel
Méndez-Ferrer, Simón
I Piruat, José
Suarez, Carlos
Chiara, María-Dolores
author_sort Merlo, Anna
collection PubMed
description The hypoxia-inducible factor 1α (HIF-1α) and its microRNA target, miR-210, are candidate tumor-drivers of metabolic reprogramming in cancer. Neuroendocrine neoplasms such as paragangliomas (PGLs) are particularly appealing for understanding the cancer metabolic adjustments because of their associations with deregulations of metabolic enzymes, such as succinate dehydrogenase (SDH), and the von Hippel Lindau (VHL) gene involved in HIF-1α stabilization. However, the role of miR-210 in the pathogenesis of SDH-related tumors remains an unmet challenge. Herein is described an in vivo genetic analysis of the role of VHL, HIF1A and SDH on miR-210 by using knockout murine models, siRNA gene silencing, and analyses of human tumors. HIF-1α knockout abolished hypoxia-induced miR-210 expression in vivo but did not alter its constitutive expression in paraganglia. Normoxic miR-210 levels substantially increased by complete, but not partial, VHL silencing in paraganglia of knockout VHL-mice and by over-expression of p76del-mutated pVHL. Similarly, VHL-mutated PGLs, not those with decreased VHL-gene/mRNA dosage, over-expressed miR-210 and accumulate HIF-1α in most tumor cells. Ablation of SDH activity in SDHD-null cell lines or reduction of the SDHD or SDHB protein levels elicited by siRNA-induced gene silencing did not induce miR-210 whereas the presence of SDH mutations in PGLs and tumor-derived cell lines was associated with mild increase of miR-210 and the presence of a heterogeneous, HIF-1α-positive and HIF-1α-negative, tumor cell population. Thus, activation of HIF-1α is likely an early event in VHL-defective PGLs directly linked to VHL mutations, but it is a late event favored but not directly triggered by SDHx mutations. This combined analysis provides insights into the mechanisms of HIF-1α/miR-210 regulation in normal and tumor tissues potentially useful for understanding the pathogenesis of cancer and other diseases sharing similar underpinnings.
format Online
Article
Text
id pubmed-5351664
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53516642017-04-13 Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate Merlo, Anna Bernardo-Castiñeira, Cristóbal Sáenz-de-Santa-María, Inés Pitiot, Ana S Balbín, Milagros Astudillo, Aurora Valdés, Nuria Scola, Bartolomé Del Toro, Raquel Méndez-Ferrer, Simón I Piruat, José Suarez, Carlos Chiara, María-Dolores Oncotarget Research Paper The hypoxia-inducible factor 1α (HIF-1α) and its microRNA target, miR-210, are candidate tumor-drivers of metabolic reprogramming in cancer. Neuroendocrine neoplasms such as paragangliomas (PGLs) are particularly appealing for understanding the cancer metabolic adjustments because of their associations with deregulations of metabolic enzymes, such as succinate dehydrogenase (SDH), and the von Hippel Lindau (VHL) gene involved in HIF-1α stabilization. However, the role of miR-210 in the pathogenesis of SDH-related tumors remains an unmet challenge. Herein is described an in vivo genetic analysis of the role of VHL, HIF1A and SDH on miR-210 by using knockout murine models, siRNA gene silencing, and analyses of human tumors. HIF-1α knockout abolished hypoxia-induced miR-210 expression in vivo but did not alter its constitutive expression in paraganglia. Normoxic miR-210 levels substantially increased by complete, but not partial, VHL silencing in paraganglia of knockout VHL-mice and by over-expression of p76del-mutated pVHL. Similarly, VHL-mutated PGLs, not those with decreased VHL-gene/mRNA dosage, over-expressed miR-210 and accumulate HIF-1α in most tumor cells. Ablation of SDH activity in SDHD-null cell lines or reduction of the SDHD or SDHB protein levels elicited by siRNA-induced gene silencing did not induce miR-210 whereas the presence of SDH mutations in PGLs and tumor-derived cell lines was associated with mild increase of miR-210 and the presence of a heterogeneous, HIF-1α-positive and HIF-1α-negative, tumor cell population. Thus, activation of HIF-1α is likely an early event in VHL-defective PGLs directly linked to VHL mutations, but it is a late event favored but not directly triggered by SDHx mutations. This combined analysis provides insights into the mechanisms of HIF-1α/miR-210 regulation in normal and tumor tissues potentially useful for understanding the pathogenesis of cancer and other diseases sharing similar underpinnings. Impact Journals LLC 2016-12-27 /pmc/articles/PMC5351664/ /pubmed/28036268 http://dx.doi.org/10.18632/oncotarget.14265 Text en Copyright: © 2017 Merlo et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Merlo, Anna
Bernardo-Castiñeira, Cristóbal
Sáenz-de-Santa-María, Inés
Pitiot, Ana S
Balbín, Milagros
Astudillo, Aurora
Valdés, Nuria
Scola, Bartolomé
Del Toro, Raquel
Méndez-Ferrer, Simón
I Piruat, José
Suarez, Carlos
Chiara, María-Dolores
Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate
title Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate
title_full Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate
title_fullStr Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate
title_full_unstemmed Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate
title_short Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate
title_sort role of vhl, hif1a and sdh on the expression of mir-210: implications for tumoral pseudo-hypoxic fate
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351664/
https://www.ncbi.nlm.nih.gov/pubmed/28036268
http://dx.doi.org/10.18632/oncotarget.14265
work_keys_str_mv AT merloanna roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT bernardocastineiracristobal roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT saenzdesantamariaines roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT pitiotanas roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT balbinmilagros roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT astudilloaurora roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT valdesnuria roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT scolabartolome roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT deltororaquel roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT mendezferrersimon roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT ipiruatjose roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT suarezcarlos roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate
AT chiaramariadolores roleofvhlhif1aandsdhontheexpressionofmir210implicationsfortumoralpseudohypoxicfate